Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000886163-16-000152
Filing Date
2016-03-03
Accepted
2016-03-03 08:46:23
Documents
2
Period of Report
2015-11-19
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd_form8-kxavireolicense.htm 8-K/A 26753
2 EXHIBIT 99.1 lgnd-vireolicenseagreement.htm EX-99.1 748268
  Complete submission text file 0000886163-16-000152.txt   776118
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 161479620
SIC: 2834 Pharmaceutical Preparations